{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:48:26Z","timestamp":1768297706488,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","award":["TUFF 65\/2567"],"award-info":[{"award-number":["TUFF 65\/2567"]}],"id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Odontology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oral lichen planus (OLP), a prevalent immune-mediated inflammatory condition, requires effective therapies. Topical corticosteroids, such as dexamethasone, are widely used for OLP treatment. However, they can predispose patients to secondary candidiasis, necessitating adjunctive therapy with antifungal agents like miconazole. Little is known about the cellular dynamics and toxicity of the combined use of dexamethasone and miconazole. This study examined the effect of dexamethasone on the antifungal activity of miconazole against\n                    <jats:italic>Candida albicans<\/jats:italic>\n                    and the effect of miconazole on the immunosuppressive activity of dexamethasone on human T cells. The cytotoxicity of dexamethasone alone and dexamethasone combined with miconazole on human oral keratinocytes and gingival fibroblasts was also determined using both in vitro monolayer and Transwell co-culture models. A 5-min incubation thrice daily cell treatment protocol was employed for all assays. Dexamethasone did not affect miconazole\u2019s antifungal efficacy, and a single exposure of miconazole inhibited over 99% of\n                    <jats:italic>C. albicans<\/jats:italic>\n                    growth. In monolayer cultures, 0.05% dexamethasone was non-toxic to keratinocytes and fibroblasts, while miconazole exhibited dose-dependent cytotoxicity at high concentrations. Transwell co-culture models confirmed this dose-dependent cytotoxicity, with higher miconazole concentrations causing increased apoptosis. Dexamethasone significantly reduced T cell viability, activation, and proliferation, unaffected by miconazole co-treatment. In conclusion, when used in combination at optimal concentrations, miconazole\u2019s antifungal activity and dexamethasone\u2019s anti-T-cell proliferation activity are retained without cytotoxicity to human oral cells. Further research is needed to validate these findings and develop evidence-based treatments for oral lichen planus.\n                  <\/jats:p>","DOI":"10.1007\/s10266-025-01119-z","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:59:31Z","timestamp":1747807171000},"page":"273-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytotoxicity and antifungal effects of combined dexamethasone and miconazole on human oral keratinocytes, gingival fibroblasts, and Candida albicans"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0595-982X","authenticated-orcid":false,"given":"Papon","family":"Muangsanit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4445-8529","authenticated-orcid":false,"given":"Supathep","family":"Tansirichaiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5943-2161","authenticated-orcid":false,"given":"Puangwan","family":"Lapthanasupkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-3393","authenticated-orcid":false,"given":"Chidchanok","family":"Leethanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-3737","authenticated-orcid":false,"given":"Kununya","family":"Pimolbutr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-1305","authenticated-orcid":false,"given":"Weerachai","family":"Singhatanadgit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"1119_CR1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/odi.13323","volume":"27","author":"M\u00c1 Gonz\u00e1lez-Moles","year":"2021","unstructured":"Gonz\u00e1lez-Moles M\u00c1, Warnakulasuriya S, Gonz\u00e1lez-Ruiz I, Gonz\u00e1lez-Ruiz L, Ay\u00e9n \u00c1, Lenouvel D, et al. Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis. Oral Dis. 2021;27:813\u201328.","journal-title":"Oral Dis"},{"issue":"80","key":"1119_CR2","first-page":"105","volume":"2019","author":"M Carrozzo","year":"2000","unstructured":"Carrozzo M, Porter S, Mercadante V, Fedele S. Oral lichen planus: a disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies. Periodontol. 2000;2019(80):105\u201325.","journal-title":"Periodontol"},{"key":"1119_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/jop.12898","volume":"48","author":"LM DeAngelis","year":"2019","unstructured":"DeAngelis LM, Cirillo N, McCullough MJ. The immunopathogenesis of oral lichen planus\u2014is there a role for mucosal associated invariant T cells? J Oral Pathol Med. 2019;48:552\u20139.","journal-title":"J Oral Pathol Med"},{"key":"1119_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/0019-5154.156315","volume":"60","author":"S Gupta","year":"2015","unstructured":"Gupta S, Jawanda MK. Oral lichen planus: an update on etiology, pathogenesis, clinical presentation. Diagnosis Manag Indian J Dermatol. 2015;60:222\u20139.","journal-title":"Diagnosis Manag Indian J Dermatol"},{"key":"1119_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.4103\/jpbs.JPBS_91_17","volume":"9","author":"MS Kiran","year":"2017","unstructured":"Kiran MS, Vidya S, Aswal GS, Kumar V, Rai V. Systemic and topical steroids in the management of oral mucosal lesions. J Pharm Bioallied Sci. 2017;9:S1-s3.","journal-title":"J Pharm Bioallied Sci"},{"key":"1119_CR6","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mcna.2014.08.006","volume":"98","author":"ET Stoopler","year":"2014","unstructured":"Stoopler ET, Sollecito TP. Oral mucosal diseases: evaluation and management. Med Clin North Am. 2014;98:1323\u201352.","journal-title":"Med Clin North Am"},{"key":"1119_CR7","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1365-2133.2012.10821.x","volume":"166","author":"G Lodi","year":"2012","unstructured":"Lodi G, Carrozzo M, Furness S, Thongprasom K. Interventions for treating oral lichen planus: a systematic review. Br J Dermatol. 2012;166:938\u201347.","journal-title":"Br J Dermatol"},{"key":"1119_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/10520295.2015.1127425","volume":"91","author":"S Arora","year":"2016","unstructured":"Arora S, Verma M, Gupta SR, Urs AB, Dhakad MS, Kaur R. Phenotypic variability and therapeutic implications of Candida species in patients with oral lichen planus. Biotech Histochem. 2016;91:237\u201341.","journal-title":"Biotech Histochem"},{"key":"1119_CR9","first-page":"585","volume":"16","author":"I Parlatescu","year":"2021","unstructured":"Parlatescu I, Nicolae C, Tovaru S, Radu L, Penes O, Varlas V. The implication of candida infection in oral lichen planus lesions. Maedica (Bucur). 2021;16:585\u20139.","journal-title":"Maedica (Bucur)"},{"key":"1119_CR10","first-page":"e1","volume":"30","author":"SS Alqahtani","year":"2023","unstructured":"Alqahtani SS, Alabeedi FM. Association of oral candidiasis with oral lichen planus in patients using corticosteroid therapy - meta-analysis. J Popul Ther Clin Pharmacol. 2023;30:e1-13.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"1119_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/odi.12399","volume":"22","author":"D Marable","year":"2016","unstructured":"Marable D, Bowers L, Stout T, Stewart C, Berg K, Sankar V, et al. Oral candidiasis following steroid therapy for oral lichen planus. Oral Dis. 2016;22:140\u20137.","journal-title":"Oral Dis"},{"key":"1119_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/odi.12380","volume":"22","author":"L-W Zhang","year":"2016","unstructured":"Zhang L-W, Fu J-Y, Hua H, Yan Z-M. Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis. Oral Dis. 2016;22:185\u201395.","journal-title":"Oral Dis"},{"key":"1119_CR13","first-page":"e172","volume":"24","author":"G Quind\u00f3s","year":"2019","unstructured":"Quind\u00f3s G, Gil-Alonso S, Marcos-Arias C, Sevillano E, Mateo E, Jauregizar N, et al. Therapeutic tools for oral candidiasis: current and new antifungal drugs. Med Oral Patol Oral Cir Bucal. 2019;24:e172\u201380.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1119_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1439-0507.2009.01728.x","volume":"53","author":"N Isham","year":"2010","unstructured":"Isham N, Ghannoum MA. Antifungal activity of miconazole against recent Candida strains. Mycoses. 2010;53:434\u20137.","journal-title":"Mycoses"},{"key":"1119_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1601-0825.1999.tb00063.x","volume":"5","author":"M Carbone","year":"1999","unstructured":"Carbone M, Conrotto D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis. 1999;5:44\u20139.","journal-title":"Oral Dis"},{"key":"1119_CR16","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1365-2133.2007.07883.x","volume":"156","author":"G Lodi","year":"2007","unstructured":"Lodi G, Tarozzi M, Sardella A, Demarosi F, Canegallo L, Di Benedetto D, et al. Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. Br J Dermatol. 2007;156:1336\u201341.","journal-title":"Br J Dermatol"},{"key":"1119_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1124\/mol.105.022046","volume":"70","author":"C Duret","year":"2006","unstructured":"Duret C, Daujat-Chavanieu M, Pascussi J-M, Pichard-Garcia L, Balaguer P, Fabre J-M, et al. Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol Pharmacol. 2006;70:329\u201339.","journal-title":"Mol Pharmacol"},{"key":"1119_CR18","unstructured":"Clinical and Laboratory Standards Institute (2017) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-fourth edition. CLSI Document M27-A4. Wayne, PA, 2017."},{"key":"1119_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010503","volume":"5","author":"RM Castilho","year":"2010","unstructured":"Castilho RM, Squarize CH, Leelahavanichkul K, Zheng Y, Bugge T, Gutkind JS. Rac1 is required for epithelial stem cell function during dermal and oral mucosal wound healing but not for tissue homeostasis in mice. PLoS ONE. 2010;5: e10503.","journal-title":"PLoS ONE"},{"key":"1119_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41405-024-00217-4","volume":"10","author":"P Wongpakorn","year":"2024","unstructured":"Wongpakorn P, Chantarangsu S, Prapinjumrune C. Factors involved in the remission of oral lichen planus treated with topical corticosteroids. BDJ Open. 2024;10:1\u20137.","journal-title":"BDJ Open"},{"key":"1119_CR21","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.4317\/medoral.25040","volume":"27","author":"M Georgaki","year":"2022","unstructured":"Georgaki M, Piperi E, Theofilou VI, Pettas E, Stoufi E, Nikitakis NG. A randomized clinical trial of topical dexamethasone vs. cyclosporine treatment for oral lichen planus. Med Oral Patol Oral Cir Bucal. 2022;27:e113\u201324.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1119_CR22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s10787-017-0418-0","volume":"26","author":"L Chen","year":"2018","unstructured":"Chen L, Jondal M, Yakimchuk K. Regulatory effects of dexamethasone on NK and T cell immunity. Inflammopharmacology. 2018;26:1331\u20138.","journal-title":"Inflammopharmacology"},{"key":"1119_CR23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/01480545.2020.1778019","volume":"45","author":"P-L Lam","year":"2022","unstructured":"Lam P-L, Wong M-M, Hung L-K, Yung L-H, Tang JC-O, Lam K-H, et al. Miconazole and terbinafine induced reactive oxygen species accumulation and topical toxicity in human keratinocytes. Drug Chem Toxicol. 2022;45:834\u20138.","journal-title":"Drug Chem Toxicol"},{"key":"1119_CR24","doi-asserted-by":"publisher","first-page":"4019723","DOI":"10.1155\/2017\/4019723","volume":"2017","author":"H-D M\u00fcller","year":"2017","unstructured":"M\u00fcller H-D, Eick S, Moritz A, Lussi A, Gruber R. Cytotoxicity and antimicrobial activity of oral rinses in vitro. Biomed Res Int. 2017;2017:4019723.","journal-title":"Biomed Res Int"},{"key":"1119_CR25","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.4317\/medoral.19472","volume":"19","author":"E Rivarola de Gutierrez","year":"2014","unstructured":"Rivarola de Gutierrez E, Di Fabio A, Salom\u00f3n S, Lanfranchi H. Topical treatment of oral lichen planus with anthocyanins. Med Oral Patol Oral Cir Bucal. 2014;19:e459\u201366.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1119_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.rpor.2020.09.012","volume":"25","author":"F Dastan","year":"2020","unstructured":"Dastan F, Ameri A, Dodge S, Hamidi Shishvan H, Pirsalehi A, Abbasinazari M. Efficacy and safety of propolis mouthwash in management of radiotherapy induced oral mucositis; a randomized, double blind clinical trial. Rep Pract Oncol Radiother. 2020;25:969\u201373.","journal-title":"Rep Pract Oncol Radiother"},{"key":"1119_CR27","first-page":"5454","volume":"10","author":"B Monshi","year":"2021","unstructured":"Monshi B, Ellersdorfer C, Edelmayer M, Dvorak G, Ganger C, Ulm C, et al. Topical cyclosporine in oral lichen planus\u2014a series of 21 open-label, biphasic. Single-Patient Observ J Clin Med. 2021;10:5454.","journal-title":"Single-Patient Observ J Clin Med"},{"key":"1119_CR28","doi-asserted-by":"publisher","first-page":"18896","DOI":"10.1038\/s41598-019-55383-5","volume":"9","author":"T Tamari","year":"2019","unstructured":"Tamari T, Elimelech R, Cohen G, Cohen T, Doppelt O, Eskander-Hashoul L, et al. Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: a major adverse effect of bisphosphonate therapy. Sci Rep. 2019;9:18896.","journal-title":"Sci Rep"},{"key":"1119_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100360","volume":"16","author":"N Li","year":"2022","unstructured":"Li N, Xie L, Wu Y, Wu Y, Liu Y, Gao Y, et al. Dexamethasone-loaded zeolitic imidazolate frameworks nanocomposite hydrogel with antibacterial and anti-inflammatory effects for periodontitis treatment. Mater Today Bio. 2022;16: 100360.","journal-title":"Mater Today Bio"},{"key":"1119_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1468-3083.1996.tb00160.x","volume":"6","author":"F Kautzky","year":"1996","unstructured":"Kautzky F, Hartinger A, K\u00f6hler LD, Vogt H-J. In vitro cytotoxicity of antimicrobial agents to human keratinocytes. J Eur Acad Dermatol Venereol. 1996;6:159\u201366.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1119_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.826123","author":"BNAS da Pimentel","year":"2022","unstructured":"da Pimentel BNAS, Marin-Dett FH, Assis M, Barbugli PA, Longo E, Vergani CE. Antifungal activity and biocompatibility of \u03b1-AgVO3, \u03b1-Ag2WO4, and \u03b2-Ag2MoO4 using a three-dimensional coculture model of the oral mucosa. Front Bioeng Biotechnol. 2022. https:\/\/doi.org\/10.3389\/fbioe.2022.826123.","journal-title":"Front Bioeng Biotechnol"},{"key":"1119_CR32","doi-asserted-by":"publisher","first-page":"901","DOI":"10.14219\/jada.archive.2001.0302","volume":"132","author":"N Chainani-Wu","year":"2001","unstructured":"Chainani-Wu N, Silverman S, Lozada-Nur F, Mayer P, Watson JJ. Oral lichen planus: patient profile, disease progression and treatment responses. J Am Dent Assoc. 2001;132:901\u20139.","journal-title":"J Am Dent Assoc"},{"key":"1119_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijantimicag.2017.03.015","volume":"50","author":"W Sun","year":"2017","unstructured":"Sun W, Wang D, Yu C, Huang X, Li X, Sun S. Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence. Int J Antimicrob Agents. 2017;50:399\u2013405.","journal-title":"Int J Antimicrob Agents"},{"key":"1119_CR34","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jac\/dkab412","volume":"77","author":"TG Jacobs","year":"2022","unstructured":"Jacobs TG, Marzolini C, Back DJ, Burger DM. Dexamethasone is a dose-dependent perpetrator of drug\u2013drug interactions: implications for use in people living with HIV. J Antimicrob Chemother. 2022;77:568\u201373.","journal-title":"J Antimicrob Chemother"},{"key":"1119_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/fsn3.122","volume":"2","author":"XF Koe","year":"2014","unstructured":"Koe XF, Tengku Muhammad TS, Chong AS-C, Wahab HA, Tan ML. Cytochrome P450 induction properties of food and herbal-derived compounds using a novel multiplex RT-qPCR in vitro assay, a drug\u2013food interaction prediction tool. Food Sci Nutr. 2014;2:500\u201320.","journal-title":"Food Sci Nutr"},{"key":"1119_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1067\/mcp.2000.110772","volume":"68","author":"T Varis","year":"2000","unstructured":"Varis T, Kivist\u00f6 KT, Backman JT, Neuvonen PJ. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Clin Pharmacol Ther. 2000;68:487\u201394.","journal-title":"Clin Pharmacol Ther"},{"key":"1119_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113396","volume":"188","author":"L Li","year":"2020","unstructured":"Li L, Li H, Wang C, Qian K, Ma P. Simultaneous determination the concentration change of ketoconazole and dexamethasone acetate: application to drug-drug interaction in human keratinocyte. J Pharm Biomed Anal. 2020;188: 113396.","journal-title":"J Pharm Biomed Anal"}],"container-title":["Odontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-025-01119-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10266-025-01119-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-025-01119-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:03:25Z","timestamp":1768269805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10266-025-01119-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1119"],"URL":"https:\/\/doi.org\/10.1007\/s10266-025-01119-z","relation":{},"ISSN":["1618-1247","1618-1255"],"issn-type":[{"value":"1618-1247","type":"print"},{"value":"1618-1255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Ethical approval for the isolation and use of human primary cells in this study was approved by the Ethics Review Sub-Committee for Research Involving Human Research Subjects of Thammasat University No. 3 (049\/2564).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}